Advantages of a fully automated chemiluminescent method for therapeutic drug monitoring (TDM) of anti-TNFα in patients with Inflammatory Bowel Diseases

被引：0
|
作者：
Cifu, A. [1 ]
Marino, M. [2 ]
Sablich, R. [3 ]
Carletti, M. [4 ]
Blasone, N. [4 ]
Milloch, S. [4 ]
Curcio, F. [1 ]
Fabris, M. [4 ]
机构：
[1] Univ Udine, Dept Med DAME, Udine, Italy
[2] Azienda Sanit Univ Friuli Cent ASUFC, Gastroenterol Clin, Udine, Italy
[3] Azienda Sanit Friuli Orientale ASFO, Gastroenterol Clin, Pordenone, Italy
[4] Azienda Sanit Univ Friuli Cent ASUFC, Inst Clin Pathol, Udine, Italy
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P241
引用
收藏
页码：I289 / I289
页数：1
相关论文
共 50 条
  • [1] Clinical value of routine therapeutic anti-TNF drug monitoring (TDM) in Inflammatory Bowel Disease (IBD) patients in clinical practice
    Guirgis, M.
    Bianchetti, D.
    Dorta, G.
    Michetti, P.
    Maillard, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 : S235 - S236
  • [2] Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease
    Frank I. Scott
    Gary R. Lichtenstein
    [J]. Current Treatment Options in Gastroenterology, 2014, 12 (1) : 59 - 75
  • [3] Therapeutic drug monitoring of anti-TNF therapy in children with inflammatory bowel disease
    van Hoeve, Karen
    Hoffman, Ilse
    Vermeire, Severine
    [J]. EXPERT OPINION ON DRUG SAFETY, 2018, 17 (02) : 185 - 196
  • [4] Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients?
    Eun, Chang Soo
    [J]. GUT AND LIVER, 2017, 11 (01) : 3 - 4
  • [5] Efficacy of therapeutic drug monitoring of anti-TNF therapy in the control of patients with inflammatory bowel disease
    Bernardo, S.
    Fernandes, S.
    Goncalves, A. R.
    Baldaia, C.
    Valente, A.
    Moura Santos, P.
    Correia, L.
    Velosa, J.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S308 - S309
  • [6] Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases
    Felice, Carla
    Marzo, Manuela
    Pugliese, Daniela
    Papa, Alfredo
    Rapaccini, Gian Lodovico
    Guidi, Luisa
    Armuzzi, Alessandro
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (08) : 1107 - 1117
  • [7] Is There a Role for Therapeutic Drug Monitoring of Anti-TNF Monoclonal Antibodies in Inflammatory Bowel Disease
    Baert, Filip
    [J]. DIGESTIVE DISEASES, 2015, 33 : 70 - 77
  • [8] Clinical impact of routine anti-Tumour Necrosis Factor (anti-TNF) therapeutic drug monitoring (TDM) in the management of Inflammatory Bowel Disease (IBD) patients
    Guirgis, M.
    Bianchetti, D.
    Dorta, G.
    Michetti, P.
    Maillard, M.
    [J]. SWISS MEDICAL WEEKLY, 2015, 145 : S3 - S3
  • [9] Clinical Impact of Routine Anti-Tumour Necrosis Factor (Anti-TNF) Therapeutic Drug Monitoring (TDM) in Management of Inflammatory Bowel Disease (IBD) Patients
    Guirgis, Marianne
    Bianchetti, Davide
    Dorta, Gian O.
    Michetti, Pierre F.
    Maillard, Michel H.
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S857 - S858
  • [10] Are We Ready for Proactive Therapeutic Drug Monitoring of Anti-TNF to Optimize Care of Patients With Inflammatory Bowel Disease?
    Charabaty, Aline
    [J]. CROHNS & COLITIS 360, 2020, 2 (01)
12345